| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
205,305
|
213,317
|
206,581
|
199,646
| | Cost of Revenue | 128,054 | 174,580 | 150,067 | 135,663 | | |
Gross Profit
|
77,251
|
38,737
|
56,514
|
63,983
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 9,320 | 9,799 | 10,327 | 10,627 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others | 38,081 | 36,937 | 36,167 | 34,179 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
29,850
|
(7,999)
|
10,020
|
19,177
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
|
-
|
-
|
-
|
|
Earnings Before Interest And Taxes | 29,850 | (7,999) | 10,020 | 19,177 |
|
Interest Expense |
-
|
-
|
-
|
-
|
|
Income Before Tax | 29,850 | (7,999) | 10,020 | 19,177 |
|
Income Tax Expense | 7,457 | (5,581) | 1,290 | 4,461 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 22,393 | (2,418) | 8,730 | 14,716 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
22,393
|
(2,418)
|
8,730
|
14,716
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
22,393
|
(2,418)
|
8,730
|
14,716
|
|
0.32(1.13%) 11:26AM EDT - Nasdaq Real Time Price